financetom
Business
financetom
/
Business
/
Update: AltaGas Sees 2025 Earnings Per Share at $2.10-$2.30, Raises Dividend 6%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: AltaGas Sees 2025 Earnings Per Share at $2.10-$2.30, Raises Dividend 6%
Dec 3, 2024 8:37 AM

11:18 AM EST, 12/03/2024 (MT Newswires) -- (Adds analyst comment.)

AltaGas (ALA.TO) on Tuesday said it expects 2025 normalized earnings per share of $2.10 to $2.30 as it released its 2025 guidance and raised its common share dividend by 6%.

The EPS guidance at the midpoint is about 2% above the 2024 figure.

The utility and natural-gas infrastructure company also forecast 2025 normalized EBITDA guidance of $1.78 billion to $1.88 billion. The guidance represents about 6% growth at the midpoint. Growth will be driven by asset-modernization investments in the utilities segment and improved utilization in the midstream segment, the company said.

"The potential of AI and datacenter demand for natural gas in Northern Virginia adds to this already robust outlook and reiterates the long-term need for safe, reliable, and affordable natural gas to keep society moving forward," said AltaGas chief executive Vern Yu.

The company's 2025 capital program is expected to be $1.4 billion, with more than half allocated to the utilities segment. About 45% will fund long-term midstream projects. The remaining budget will be used on digital and systems initiatives to improve operating efficiency.

AltaGas also increased its dividend to $1.26 per common share per year. The company extended its 5%-7% compounded annual growth rate guidance on dividends to 2029.

National Bank of Canada kept its outperform rating and $39.00 price target for the company's shares following the news.

The bank said its target is based on a risk-adjusted dividend yield of 3.3% applied to its estimated 2025 dividend of $1.26 per share, a 14.5x multiple of its estimated 2025 Free-EBITDA and discounted cash flow valuation of $41.25 per share.

"With 2025 financial guidance largely in line with our current estimates, combined with a modestly higher capex profile (bumping up our longer-term estimates), we expect modest changes to our current estimates and valuation ahead of rolling over our valuation estimates to 2026 early in the new year," National Bank said.

AltaGas shares were last seen up $0.45 to $34.59 on the Toronto Stock Exchange.

Price: 34.61, Change: +0.47, Percent Change: +1.38

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brazil's Petrobras to sign deal for four new support vessels built locally
Brazil's Petrobras to sign deal for four new support vessels built locally
Dec 23, 2024
RIO DE JANEIRO (Reuters) - Brazil's Transpetro, a unit of state-run oil firm Petrobras, said on Monday that local shipbuilding firms Ecovix and Mac Laren had won a tender to build four new coastal vessels for $69.5 million per vessel. WHY IT'S IMPORTANT The bid is the first step of Petrobras' plan to renew its fleet of support vessels, and...
Psyence Biomedical Expects to Raise $2 Million From Private Placement
Psyence Biomedical Expects to Raise $2 Million From Private Placement
Dec 23, 2024
08:40 AM EST, 12/23/2024 (MT Newswires) -- Psyence Biomedical ( PBM ) said Monday it has agreed to a private placement of 1 million common shares or pre-funded warrants, along with accompanying series A and series B warrants, priced at $2 each for expected gross proceeds of $2 million. The company said the series A warrants expire in five years,...
Toyota to build plant to produce EVs in China, Nikkei reports
Toyota to build plant to produce EVs in China, Nikkei reports
Dec 23, 2024
TOKYO, Dec 23 (Reuters) - Toyota Motor ( TM ) has decided to build a new factory to produce electric vehicles in China, the Nikkei business daily reported on Monday. The company will produce its luxury car brand Lexus at a new plant in Shanghai, the Nikkei reported citing several sources. Toyota ( TM ) has worked in China via...
Nuvation Bio's Lung Cancer Drug Candidate Taletrectinib Gets FDA Priority Review
Nuvation Bio's Lung Cancer Drug Candidate Taletrectinib Gets FDA Priority Review
Dec 23, 2024
08:37 AM EST, 12/23/2024 (MT Newswires) -- Nuvation Bio ( NUVB ) said Monday the US Food and Drug Administration has accepted its new drug application for drug candidate taletrectinib intended for the treatment of non-small cell lung cancer. The FDA granted priority review and set a Prescription Drug User Fee Act goal date of June 23, Nuvation said. Nuvation...
Copyright 2023-2025 - www.financetom.com All Rights Reserved